1. Home
  2. GTEC vs LEXX Comparison

GTEC vs LEXX Comparison

Compare GTEC & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Technologies Holding Corporation

GTEC

Greenland Technologies Holding Corporation

HOLD

Current Price

$1.06

Market Cap

17.7M

Sector

Industrials

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.70

Market Cap

17.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTEC
LEXX
Founded
2006
2004
Country
United States
Canada
Employees
N/A
7
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
17.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTEC
LEXX
Price
$1.06
$0.70
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
463.9K
1.5M
Earning Date
11-07-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$86,168,664.00
$705,923.00
Revenue This Year
$5.64
$13.35
Revenue Next Year
$3.93
$78.83
P/E Ratio
$0.88
N/A
Revenue Growth
N/A
52.05
52 Week Low
$0.58
$0.46
52 Week High
$2.92
$2.38

Technical Indicators

Market Signals
Indicator
GTEC
LEXX
Relative Strength Index (RSI) 58.42 42.57
Support Level $0.58 $0.46
Resistance Level $1.15 $0.72
Average True Range (ATR) 0.10 0.09
MACD 0.02 0.01
Stochastic Oscillator 80.73 86.68

Price Performance

Historical Comparison
GTEC
LEXX

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: